Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic <i>KRAS</i> and <i>ERBB2</i> ( <i>Her2</i> ) Driver Mutations
2019 · Cancer Immunology Research · 86 citations
https://doi.org/10.1158/2326-6066.cir-18-0402